Paradigm Biopharmaceuticals Ltd.ASX: PAR

PARs drug reduces cartilage degradation in subjects with OA

Aug 29, 2019 at 2:47 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment